Ticker: TSX – TOS
Shares Outstanding: 73,000,906
QUEBEC CITY, April 28, 2014 /CNW Telbec/ - TSO3 Inc. ("TSO3") (TSX: TOS) will report first quarter (Q1) 2014 financial results, for the period ended March 31, 2014 via press release on Wednesday May 7, 2014. TSO3 will also hold its Annual General Meeting of Shareholders at 10:30 A.M. (EDT) the same day.
The Annual General Meeting of Shareholders will be held at the Palais Montcalm, boardroom d'Youville, 995, Place d'Youville, Québec (Québec) at 10:30 A.M. (EDT).
For those who are unable to attend in person, we invite you to listen to the live webcast of the Annual General Meeting of Shareholders via CNW's website at:
The webcast will then be archived for a 90-day period.
TSO3, founded in Québec City in 1998, specializes in the research and development of innovative, high-performance medical instrument sterilization technology with high commercial potential. TSO3 designs products for sterile processing areas in the hospital environment and offers an advantageous replacement solutions to other low temperature sterilization processes currently used in hospitals.
For more information about TSO3, visit the Company's Web site at www.tso3.com
The statements in this release and oral statements made by representatives of TSO3 relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO3) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO3 to obtain financing on favourable terms and other risks and uncertainties.
SOURCE: TSO3 Inc.
For further information: R.M. (Ric) Rumble, President and CEO, (418) 651-0003, Ext. 254, Email: firstname.lastname@example.org